Maze Runner: The Death Cure Delayed Indefinitely


Maze Runner: The Death Cure has been delayed indefinitely to allow Dylan O'Brien a full recovery.

Maze Runner: The Death Cure has been delayed indefinitely to allow Dylan O’Brien to make a full recovery

Production on 20th Century Fox‘s Maze Runner: The Death Cure has been delayed indefinitely today to allow leading man Dylan O’Brien to make a full recovery from the injuries he sustained during a tragic on set accident last month. Thankfully, the star appears to be on the road to a full recovery but it is expected to take somewhat longer than the initial six-week estimate. As such, the planned February 17, 2017 release for Death Cure has been cancelled with a new release date expected to be announced shortly. 

“The resumption of principal photography on ‘Maze Runner: The Death Cure’ has been further delayed to allow Dylan O’Brien more time to fully recover from his injuries,” reads the official statement. “We wish Dylan a speedy recovery and look forward to restarting production as soon as possible.”

“He’s healing very well,” costar Giancarlo Esposito recently told E!. “He got put together a couple of weeks ago… He’s one tough cookie. He got his bell rung. I would imagine many who witnessed thought that was it… [But] he’s a survivor. The one good thing about Dylan that I think is going to help him get back on schedule with us very soon is he has a great attitude.”

As with the previous two movies in the franchise, Maze Runner: The Death Cure is directed by Wes Ball from a screenplay by T.S. Nowlin, adapting the YA novels of James Dashner. It follows the events of 2014’s The Maze Runner and 2015’s Maze Runner: The Scorch Trials, and co-stars Thomas Brodie-Sangster, Rosa Salazar, Ki Hong Lee and Dexter Darden.

Check back for updates on Maze Runner: The Death Cure as they become available. You can also tweet any get well soon wishes to Dylan O’Brien directly at his official twitter page.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *